XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   73,317      
Beginning balance at Dec. 31, 2023 $ 538,085 $ 73 $ 942,280 $ 582 $ (404,850)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of new capped calls associated with the 2029 convertible senior notes (93,438)   (93,438)    
Partial termination of existing capped calls associated with the 2025 convertible senior notes 539   539    
Issuance of common stock upon exercise of stock options (in shares)   15      
Issuance of common stock upon exercise of stock options 397   397    
Issuance of common stock upon vesting of restricted stock units (in shares)   1,178      
Issuance of common stock upon vesting of restricted stock units 2 $ 2      
Issuance of common stock under ESPP (in shares)   209      
Issuance of common stock under ESPP 9,522   9,522    
Stock-based compensation 91,748   91,748    
Other comprehensive loss (1,084)     (1,084)  
Net income (loss) (19,893)       (19,893)
Ending balance (in shares) at Jun. 30, 2024   74,719      
Ending balance at Jun. 30, 2024 525,878 $ 75 951,048 (502) (424,743)
Beginning balance (in shares) at Mar. 31, 2024   73,849      
Beginning balance at Mar. 31, 2024 483,598 $ 74 895,754 (303) (411,927)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   1      
Issuance of common stock upon exercise of stock options 11   11    
Issuance of common stock upon vesting of restricted stock units (in shares)   660      
Issuance of common stock upon vesting of restricted stock units 1 $ 1      
Issuance of common stock under ESPP (in shares)   209      
Issuance of common stock under ESPP 9,522   9,522    
Stock-based compensation 45,761   45,761    
Other comprehensive loss (199)     (199)  
Net income (loss) (12,816)       (12,816)
Ending balance (in shares) at Jun. 30, 2024   74,719      
Ending balance at Jun. 30, 2024 525,878 $ 75 951,048 (502) (424,743)
Beginning balance (in shares) at Dec. 31, 2024   75,808      
Beginning balance at Dec. 31, 2024 622,192 $ 76 1,039,125 636 (417,645)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   5      
Issuance of common stock upon exercise of stock options 30   30    
Issuance of common stock upon vesting of restricted stock units (in shares)   1,113      
Issuance of common stock upon vesting of restricted stock units   $ 1 (1)    
Issuance of common stock under ESPP (in shares)   337      
Issuance of common stock under ESPP 7,921   7,921    
Stock-based compensation 86,032   86,032    
Other comprehensive loss (528)     (528)  
Net income (loss) 1,730       1,730
Ending balance (in shares) at Jun. 30, 2025   77,263      
Ending balance at Jun. 30, 2025 717,377 $ 77 1,133,107 108 (415,915)
Beginning balance (in shares) at Mar. 31, 2025   76,243      
Beginning balance at Mar. 31, 2025 664,286 $ 76 1,080,782 497 (417,069)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   5      
Issuance of common stock upon exercise of stock options 28   28    
Issuance of common stock upon vesting of restricted stock units (in shares)   678      
Issuance of common stock upon vesting of restricted stock units   $ 1 (1)    
Issuance of common stock under ESPP (in shares)   337      
Issuance of common stock under ESPP 7,921   7,921    
Stock-based compensation 44,377   44,377    
Other comprehensive loss (389)     (389)  
Net income (loss) 1,154       1,154
Ending balance (in shares) at Jun. 30, 2025   77,263      
Ending balance at Jun. 30, 2025 $ 717,377 $ 77 $ 1,133,107 $ 108 $ (415,915)